Ekf Diagnostics Sustainability Profile
Ekf Diagnostics, officially known as EKF Diagnostics Holdings plc, is a prominent player in the global diagnostics industry, headquartered in Great Britain. Founded in 2000, the company has established itself as a leader in point-of-care testing and laboratory diagnostics, with a strong operational presence across Europe, North America, and Asia. Specialising in innovative products such as blood glucose monitoring systems, haemoglobin analysers, and molecular diagnostics, EKF Diagnostics is recognised for its commitment to quality and accuracy. The company’s unique approach combines advanced technology with user-friendly designs, catering to the needs of healthcare professionals and patients alike. With a solid market position, EKF Diagnostics has achieved significant milestones, including strategic partnerships and a growing portfolio of patented technologies, solidifying its reputation as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Ekf Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ekf Diagnostics's score of 25 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ekf Diagnostics's reported carbon emissions
In 2023, EKF Diagnostics, headquartered in Great Britain, reported total carbon emissions of approximately 473,000 kg CO2e. This figure includes 99,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from mobile and stationary combustion, and 374,000 kg CO2e from Scope 2 emissions, primarily from purchased electricity. Notably, there is no reported data for Scope 3 emissions. Comparatively, in 2022, EKF Diagnostics' emissions totalled approximately 338,000 kg CO2e in Great Britain, indicating a rise in emissions year-on-year. The breakdown for 2022 shows 46,000 kg CO2e from Scope 1 and 292,000 kg CO2e from Scope 2. Despite these figures, EKF Diagnostics has not set specific reduction targets or initiatives as part of their climate commitments. The company does not currently participate in initiatives such as the Science Based Targets initiative (SBTi) or disclose any climate pledges. The emissions data is sourced directly from EKF Diagnostics Holdings plc, with no cascading from a parent organization. As the company continues to assess its environmental impact, further commitments and strategies may be developed in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 46,181,000 |
| Scope 2 | 291,808,000 |
| Scope 3 | - |
How Carbon Intensive is Ekf Diagnostics's Industry?
How Carbon Intensive is Ekf Diagnostics's Location?
Ekf Diagnostics's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ekf Diagnostics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
